Form 4: Tandem Diabetes Care: Executive Stock Grant Details

Shannon Marie Hansen of Tandem Diabetes Care Inc. received a grant of 29,136 Restricted Stock Units (RSUs) on May 29, 2026, with vesting scheduled over the next several years.

Summary

• Shannon Marie Hansen, EVP & Chief Legal Officer at Tandem Diabetes Care Inc. (TNDM), was granted 29,136 Restricted Stock Units (RSUs) on May 29, 2026.
• These RSUs represent a contingent right to receive either one share of common stock or cash in lieu thereof.
• Vesting is structured such that one-third of the RSUs vest on May 29, 2027, with the remainder vesting in eight equal quarterly installments thereafter.
• The grant is made under the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it details a standard executive stock grant rather than significant financial performance or strategic shifts.

Positives

• Grant of a significant number of RSUs (29,136) to a key executive, indicating continued investment in management retention and incentivization.
• Clear vesting schedule provides a long-term incentive for the executive to remain with the company and contribute to its success.

Risks

• The value of the RSUs is subject to the future performance of Tandem Diabetes Care's stock price.
• Vesting is contingent on continued employment, meaning the executive could forfeit unvested RSUs if they leave the company before the vesting dates.

Future Outlook

The vesting schedule for the RSUs indicates a forward-looking incentive tied to continued employment and company performance over the next several years.

Industry Context

StockSavvy.ai notes that the issuance of Restricted Stock Units to executives is a common practice in the medical device industry, including diabetes care, to align executive interests with shareholder value and retain key talent.

Stakeholder Impact

• Shareholders: The grant of RSUs is a form of compensation that can dilute existing share ownership over time, but it also aims to incentivize management to increase shareholder value.
• Employees: Standard practice for executive compensation, may influence morale and retention of other key personnel.
• Management: Direct financial incentive tied to company performance and stock price.

Next Steps

• Vesting of RSUs according to the schedule: one-third on May 29, 2027, and the remainder in eight equal quarterly installments thereafter.

Key Dates

Keywords

Tandem Diabetes Care, TNDM, Form 4, SEC Filing, Restricted Stock Units, RSU, Executive Compensation, Stock Grant, Shannon Marie Hansen, Insider Trading, Beneficial Ownership